The novel Bruton's tyrosine kinase inhibitor ARQ531 disrupts survival signaling and triggers apoptosis in AML cells

被引：0
|
作者：
Debora, Soncini [1 ]
Orecchioni, Stefania [2 ]
Cagnetta, Antonia [1 ]
Retali, Veronica [1 ]
Ruberti, Samantha [1 ]
Minetto, Paola [1 ]
Contini, Paola [1 ]
Nencioni, Alessio [1 ]
Monacelli, Fiammetta [1 ]
Hall, Terence [3 ]
Gobbi, Marco [1 ]
Eathiraj, Sudharshan [3 ]
Schwartz, Briam [3 ]
Bertolini, Francesco [2 ]
Lemoli, Roberto [1 ]
Cea, Michele [1 ]
机构：
[1] Univ Genoa, Genoa, Italy
[2] European Inst Oncol, Milan, Italy
[3] ARQULE, Burlington, MA USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-793
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
793
引用
收藏
页数：2
相关论文
共 50 条
  • [1] THE NOVEL BRUTON'S TYROSINE KINASE INHIBITOR ARQ531, DISRUPTS SURVIVAL SIGNALING AND TRIGGERS APOPTOSIS IN AML CELLS
    Soncini, D.
    Minetto, P.
    Ruberti, S.
    Retali, V.
    Orecchioni, S.
    Contini, P.
    Cagnetta, A.
    Eathiraj, S.
    Abbadessa, G.
    Schwartz, B.
    Nencioni, A.
    Todoerti, K.
    Agnelli, L.
    Bertolini, F.
    Neri, A.
    Gobbi, M.
    Lemoli, R. M.
    Cea, M.
    HAEMATOLOGICA, 2018, 103 : S71 - S71
  • [2] PRECLINICAL ACTIVITY OF NOVEL BRUTON'S TYROSINE KINASE INHIBITOR ARQ531 ON MULTIPLE MYELOMA CELLS
    Retali, V.
    Soncini, D.
    Minetto, P.
    Ruberti, S.
    Contini, P.
    Rivoli, G.
    Bisso, N.
    Di Felice, N.
    Cagnetta, A.
    Eathiraj, S.
    Abbadessa, G.
    Schwartz, B.
    Gobbi, M.
    Lemoli, R. M.
    Cea, M.
    HAEMATOLOGICA, 2018, 103 : S114 - S114
  • [3] MLN0128, a novel mTOR kinase inhibitor, disrupts survival signaling and triggers apoptosis in AML and AML stem/progenitor cells
    Zeng, Zhihong
    Wang, Rui-Yu
    Qiu, Yi Hua
    Mak, Duncan H.
    Coombes, Kevin
    Yoo, Suk Young
    Zhang, Qi
    Jessen, Katti
    Liu, Yi
    Rommel, Christian
    Fruman, David A.
    Kantarjian, Hagop M.
    Kornblau, Steven M.
    Andreeff, Michael
    Konopleva, Marina
    ONCOTARGET, 2016, 7 (34) : 55083 - 55097
  • [4] Preclinical evaluation of the tyrosine kinase inhibitor ARQ 531 in AML
    Elgamal, Ola A.
    Carmichael, Bridget
    Lehman, Amy
    Orwick, Shelley J.
    Minh Tran
    Goettl, Virginia M.
    Mitchell, Shaneice
    Lapalombella, Rosa
    Jeon, Jae Yoon
    Baker, Sharyn D.
    Eathiraj, Sudharshan
    Schwartz, Brian
    Hertlein, Erin
    Byrd, John C.
    CANCER RESEARCH, 2018, 78 (13)
  • [5] MLN0128, a Second-Generation mTOR Kinase Inhibitor, Disrupts Survival Signaling and Triggers Apoptosis in AML
    Zeng, Zhihong
    Wang, Rui-Yu
    Shi, Yuexi
    Qiu, Yihua
    Mak, Duncan H.
    Coombes, Kevin
    Yoo, Suk Young
    Jessen, Katti
    Liu, Yi
    Rommel, Christian
    Kantarjian, Hagop M.
    Kornblau, Steven M.
    Fruman, David
    Andreeff, Michael
    Konopleva, Marina
    BLOOD, 2014, 124 (21)
  • [6] ARQ 531, a novel and reversible inhibitor of Bruton's tyrosine kinase, displays favorable oral bioavailability and exposure in patients with B-cell malignancies
    Hall, Terence
    Yu, Yi
    Eathiraj, Sudharshan
    Stephens, Deborah
    Flinn, Ian
    Woyach, Jennifer
    Schwartz, Brian
    Savage, Ronald E.
    CANCER RESEARCH, 2018, 78 (13)
  • [7] The new small tyrosine kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs
    Soncini, Debora
    Orecchioni, Stefania
    Ruberti, Samantha
    Minetto, Paola
    Martinuzzi, Claudia
    Agnelli, Luca
    Todoerti, Katia
    Cagnetta, Antonia
    Miglino, Maurizio
    Clavio, Marino
    Contini, Paola
    Varaldo, Riccardo
    Bergamaschi, Micaela
    Guolo, Fabio
    Passalacqua, Mario
    Nencioni, Alessio
    Monacelli, Fiammetta
    Gobbi, Marco
    Neri, Antonino
    Abbadessa, Giovanni
    Eathiraj, Sudharshan
    Schwartz, Brian
    Bertolini, Francesco
    Lemoli, Roberto M.
    Cea, Michele
    HAEMATOLOGICA, 2020, 105 (10) : 2420 - 2431
  • [8] Novel leflunomide analog inhibitor of Bruton's tyrosine kinase
    Mahajan, S
    Ghosh, S
    Sudbeck, E
    Zheng, YG
    Downs, S
    Uckun, FM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U283 - U283
  • [9] A novel dual inhibitor of microtubule and Bruton's tyrosine kinase inhibits survival of multiple myeloma and osteoclastogenesis
    Pandey, Manoj K.
    Gowda, Krishne
    Sung, Shen-shu
    Abraham, Thomas
    Budak-Alpdogan, Tulin
    Talamo, Giampolo
    Dovat, Sinisa
    Amin, Shantu
    EXPERIMENTAL HEMATOLOGY, 2017, 53 : 31 - 42
  • [10] AMG925, a Dual FLT3-CDK4/6 Inhibitor, Disrupts Survival Signaling and Triggers Apoptosis in AML Progenitor/Stem Cells
    Zeng, Zhihong
    Ly, Charlie
    Mak, Duncan
    Shah, Neil P.
    Konopleva, Marina
    Andreeff, Michael
    BLOOD, 2016, 128 (22)
12345